ADC & Radiopharmaceuticals Pharma & Biotech Partnering Summit
R&D
Major moves in pharma and biotech partnering are reshaping the landscape. For ADC companies, the challenge lies in standing out, validating their offerings, and securing clinical-ready assets amidst this whirlwind of activity.
How does one differentiate and obtain assets poised for clinical success in the next wave of deals?
Enter the ADC & Radiopharmaceuticals Pharma & Biotech Partnering Summit.
- Cuts through the noise of partnership events to gather a targeted critical mass of 100+ ADC companies
- Provides a platform for networking and fast-tracking the search and evaluation of earlier development assets
- Empowers participants to navigate the complex partnering landscape with confidence by significantly improving the alignment, efficiency, and yield of conversations
If you have any questions, please get in touch with the team here: info@hansonwade.com
- Understand how to transition your potency assay from early to late-stage
- Explore how NGS methods can better inform your genome titers
- Accurately measure partials in your samples
- Produce contaminant-free and high yield vector batches at scale
Secure your place here or get in touch with the team – info@hansonwade.com
